NCT04711265 Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys Status COMPLETED Phase N/A
NCT04661813 Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV Status COMPLETED Phase NA
NCT04620291 Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults Status NOT_YET_RECRUITING Phase PHASE1
NCT04605354 Epidemiological and Clinical Description of Women Living With HIV in Selected Countries of Latin America Status UNKNOWN Phase N/A
NCT04596488 Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients Status COMPLETED Phase NA
NCT04568239 Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES) Status COMPLETED Phase N/A
NCT04563962 Contingency Management for PrEP Adherence and/or Methamphetamine Use Status COMPLETED Phase NA
NCT04553081 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial Status RECRUITING Phase PHASE4
NCT04553016 A Study to Test Three Experimental HIV Vaccines in Healthy Adults. Status UNKNOWN Phase PHASE1
NCT04549467 Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test Status COMPLETED Phase PHASE4
NCT04538040 Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine Status COMPLETED Phase PHASE4
NCT04526977 Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis). Status UNKNOWN Phase N/A
NCT04517825 More Than a Machine: Make Point-of-care HIV-1 Viral Load Testing Effective in Rural Uganda Status COMPLETED Phase N/A